Viva Biotech Holdings (hkse:01873) Share Price

Company Profile

Business description
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
Contact
735 Ziping Road
Pudong New District
Zhoupu Town
Shanghai201318
CHN
T: +86 2160893288
https://www.vivabiotech.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
2,213

Recommended

These shares are trading at a discount to our fair value discount and have sustainable competitive advantages.

Morningstar | 11 November 2026

There may be meaningful upside as Anthropic is pricing its stock as a reflection of current sentiment, not the company’s fundamentals.

Malik Ahmed Khan, CFA | 11 November 2026

Strong fundamentals meet a demanding valuation.

Esther Holloway | 11 November 2026

Index	Last price	Change	% Change
All Ordinaries	9,274.20	17.10	-0.18%
CAC 40	8,342.51	9.64	0.12%
DAX 40	26,694.28	31.51	0.12%
Dow JONES (US)	52,420.14	66.35	-0.13%
FTSE 100	10,823.90	11.57	-0.11%
HKSE	24,008.55	307.37	-1.26%
NASDAQ	25,305.88	160.31	-0.63%
Nikkei 225	60,819.36	429.23	-0.70%
NZX 50 Index	14,259.23	79.37	0.56%
S&P 500	7,587.90	31.48	-0.41%
S&P/ASX 200	9,146.80	6.40	-0.07%
SSE Composite Index	3,655.83	24.81	-0.67%